Imperial to train more leaders in artificial intelligence thanks to UKRI funding
How Cassini changed our view of Saturn and its moons
New sensor technology can diagnose reproductive health problems in real-time
CDDS researchers work across a wide range of diseases, from infection and inflammation to oncology, cardiovascular disease and neurodegeneration.
View our network of disease experts
The CDDS brings together expertise in new screening technologies, target deconvolution, ultrasensitive biomarker analysis, microfluidic devices, and more.
View technology areas
We are developing small molecule, peptide, biological and cell-based modalities across a wide range of target classes and novel modes of action.
View target classes